Navigation Links
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
Date:11/10/2008

$27.2

Hill-Rom Depreciation & Amortization $24.4 $21.5

(1) For fiscal year 2008, discrete tax benefits totaled $8.3 million

($0.13 per share), $7.8 million ($0.12 per share) of which was

recognized in the third fiscal quarter, principally associated with

the release of valuation allowances on foreign tax credit

carryforwards and the recognition of certain previously unrecognized

tax benefits associated with recently completed tax audits. Discrete

period tax adjustments have also been recognized in other quarterly

periods, but in much less significant amounts.

(2) Consolidated cash flow amounts are "as reported" and thus include cash

flows from the funeral services business through March 31, 2008.

(3) Beginning June 30, 2008, investment securities were classified as long

term assets on the balance sheet.

Consolidated Results - Highlights

Revenues from Continuing Operations

Y/Y Constant

Q4 2008 Foreign Q4 2008 Q4 2007 Currency

Actual Exchange Adjusted Actual Change

($ In Millions)

Acute Care $272.5 $(0.2) $272.3 $250.6 8.7%

Post Acute Care 50.3 - 50.3 38.8 29.6%

International and

Surgical 103.3 (4.0) 99.3 84.0 18.2%

Eliminations (1.8) - (1.8) (1.4) 28.6%

Total $424.3 $(4.2) $420.1 $372.0 12.9%

Y/Y Constant

YTD 2008 Foreign YTD 2008 YTD 2007 Currency

Actual Exchange Adjusted Actual Change

Acute Care
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... Upland, California (PRWEB) , ... June 26, 2015 ... ... preparation devices, today announced that its SimplePrep™ technologies have been integrated into a ... the International Space Station (ISS) as a part of the NASA’s WetLab-2 Project. ...
(Date:6/26/2015)... ON (PRWEB) , ... June 26, 2015 , ... ... and end-to-end services and a subsidiary of OraSure Technologies, Inc. (Nasdaq: OSUR) today ... microbiome research, as part of its Gut Microbiome Grant Program. The company has ...
(Date:6/26/2015)... ... , ... ReliantHeart, Inc. , an innovative supplier of advanced mechanical circulatory ... HeartAssist5® LVAD (HA5) to the 68th consecutive implant, there has been no evidence of ... LVAD is referred to as de novo thrombus. De novo thrombus can hide under ...
(Date:6/25/2015)... , June 25, 2015 ... ) has announced the addition of ... the Global Cancer Diagnostics Industry: Oncogenes, ... Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:Claremont BioSolutions’ SimplePrep™ Products Deployed in NASA Wetlab-2 Project Slated for June 28th Flight to International Space Station aboard SpaceX CRS-7 2Claremont BioSolutions’ SimplePrep™ Products Deployed in NASA Wetlab-2 Project Slated for June 28th Flight to International Space Station aboard SpaceX CRS-7 3DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 3HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 2Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 3
... , SAN DIEGO , July 20 Volcano Corporation ... therapy guidance tools designed to enhance the diagnosis and treatment of coronary ... results for the second quarter and first six months of fiscal 2010 ... , , ...
... , July 19 Univfy, a pioneer in ... prognostic tools, announced today the publication of new research findings ... Sciences ( PNAS ) by its founding scientific team ... paper details their development of the first rigorously validated prognostic ...
... 19 "Amira Pharmaceuticals, Inc. announced today that its FLAP ... milestones." , , , ... the successful progression of the program to Phase 2 studies, which explore the ... , , , ...
Cached Biology Technology:Volcano Corporation Schedules Second Quarter Conference Call, Webcast 2Univfy and Stanford Scientists Develop the First Personalized Prognostic Test to Predict Live Birth Outcomes with In Vitro Fertilization 2Univfy and Stanford Scientists Develop the First Personalized Prognostic Test to Predict Live Birth Outcomes with In Vitro Fertilization 3Univfy and Stanford Scientists Develop the First Personalized Prognostic Test to Predict Live Birth Outcomes with In Vitro Fertilization 4Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program 2
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... reporting evidence that certain ingredients in shampoo, detergents and ... precursor materials for formation of a suspected cancer-causing contaminant ... plants. The study sheds new light on possible environmental ... which is of ongoing concern to health officials. Their ...
... Elsevier, the world-leading provider of scientific, technical and ... initiative for the Chinese market which involves the establishment ... Center School of Distance Learning for Medical Education (PUHSC). ... affiliated to PUHSC and Elsevier, signed an agreement today ...
... bacteria counts, in more than 70 percent of bottled ... United States Pharmacopeia (USP). Researchers from Ccrest laboratories ... of the American Society for Microbiology in San Diego. ... number of urban Canadians are switching over to bottled ...
Cached Biology News:Elsevier and Peking University Health Science Center develop new China online CME service 2Study finds high level of bacteria in bottled water in Canada 2